Home > List All Publishers > BioSeeker Group AB

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.
BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker Group clients and projects are kept confidential.

List of reports from BioSeeker Group AB

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market 3/7/2011 \| published by: BioSeeker Group AB ... into 205 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. BioSeeker has applied its unique drug assessment methodology to stratify the colorectal cancer pipeline and discern the level of ... \| more...	$2,828.00
A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market 4/25/2011 \| published by: BioSeeker Group AB ... 193 drug target strategies, and assesses them in eight different compound strategies and eight subindications of leukemia. BioSeeker has applied its unique drug assessment methodology to stratify the leukemia pipeline and discern the level of ... \| more...	$2,925.00
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 5/18/2011 \| published by: BioSeeker Group AB ... 173 drug target strategies, and assesses them in eight different compound strategies and five subindications of lymphoma. BioSeeker has applied its unique drug assessment methodology to stratify the lymphoma pipeline and discern the level of ... \| more...	$2,925.00
A Decision Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market 11/17/2010 \| published by: BioSeeker Group AB ... 151 drug target strategies, and assesses them in eight different compound strategies in melanoma. BioSeeker has applied its unique drug assessment methodology to stratify the melanoma pipeline and discern the level of competition in fine ... \| more...	$2,730.00
A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market 5/24/2010 \| published by: BioSeeker Group AB ... drugs, organized into 187 drug target strategies, and assesses them in prostate cancer. Significantly new prostate cancer therapies will soon come to challenge old established drugs on the market. Four out of five target strategies ... \| more...	$2,828.00
A Shift in Cancer Immunotherapy Strategies? 7/25/2003 \| published by: BioSeeker Group AB ... projects (more 425 clinical trials of which 60 are in phase III) in order to elucidate changes in strategies for cancer immunotherapy. Conference information from the latest meeting held by the American Society of Clinical ... \| more... Buy by the section \| Search inside this report	$3,712.50
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2011 2/1/2011 \| published by: BioSeeker Group AB ... In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 111 drugs. Alpha6 Beta4 Integrin Signaling Pathway In Oncology Drug Pipeline Update lists all ... \| more...	$2,249.00
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 125 drugs. Alpha6 Beta4 Integrin Signaling Pathway In Oncology Drug Pipeline Update lists all ... \| more...	$2,249.00
Analytical Tool - Apoptosis in Oncology 2/21/2012 \| published by: BioSeeker Group AB ... time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current ... \| more...	$4,650.00
Analytical Tool - Analysis of Cancer Immunotherapy: The World Guide 3/13/2006 \| published by: BioSeeker Group AB ... type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group CD-ROM searchable databases gives better overview ... \| more...	$7,735.00
Analytical Tool - Analysis of Melanoma R&D: The Complete Guide 6/28/2005 \| published by: BioSeeker Group AB ... time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. This tool provides you with an immense amount of ... \| more...	$5,279.00
Analytical Tool - Angiogenesis in Oncology 2/21/2012 \| published by: BioSeeker Group AB ... time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current ... \| more...	$4,650.00
Analytical Tool - Antibodies and Peptides in Oncology 2/21/2012 \| published by: BioSeeker Group AB ... competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product ... \| more...	$8,925.00
Analytical Tool - Apoptosis: Promise or deception? 5/6/2005 \| published by: BioSeeker Group AB ... advanced are analyzed for their success and failure. In all, more than 60 companies are included for their R&D activities within the field. The five major targets in apoptosis, p53, Bcl-2, TRAIL, IAP and Caspases, ... \| more...	$6,402.00
Analytical Tool - Breast Cancer 2/21/2012 \| published by: BioSeeker Group AB ... of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and ... \| more...	$4,650.00
Analytical Tool - Breast Cancer R&D Comprehensive Guide 4/12/2005 \| published by: BioSeeker Group AB ... new drugs nder development. As new data is emerging, for the ecent approved aromatase inhibitor, the therapeutic options are about to change. Replacing Tamoxifen, a selective estrogen receptor modulator that has been used for more ... \| more...	$7,722.00
Analytical Tool - Breast Cancer Therapeutics & Competitive Insights 5/10/2007 \| published by: BioSeeker Group AB ... same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of ... \| more...	$4,340.00
Analytical Tool - Cancer Immunotherapy 2/21/2012 \| published by: BioSeeker Group AB ... map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies ... \| more...	$8,925.00
Analytical Tool - Cancer Therapeutic Antibodies 2/21/2012 \| published by: BioSeeker Group AB ... time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current ... \| more...	$5,924.00
Analytical Tool - Cancer Vaccines 2/21/2012 \| published by: BioSeeker Group AB ... research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. ... \| more...	$4,650.00
Analytical Tool - Colorectal Cancer 2/21/2012 \| published by: BioSeeker Group AB ... of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and ... \| more...	$4,650.00
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology 5/10/2007 \| published by: BioSeeker Group AB ... It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, ... \| more...	$4,340.00
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology 10/10/2006 \| published by: BioSeeker Group AB ... It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, ... \| more...	$4,030.00
Analytical Tool - Competitive Outlook on Cancer Vaccines 8/4/2006 \| published by: BioSeeker Group AB ... of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and ... \| more...	$4,092.00
Analytical Tool - Competitive Outlook on Cancer Vaccines 5/10/2007 \| published by: BioSeeker Group AB ... of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and ... \| more...	$4,340.00

< prev 1 2 3 4 5 6 7 8 9 10 next >